Vivani Medical Newsroom

Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 14 10:32 ET

Vivani Medical Gains 'Buy' Rating Due to Strategic Advancements and Financial Strength

TipRanksNov 14 10:30 ET

Vivani Medical Analyst Ratings

BenzingaNov 7 15:37 ET

H.C. Wainwright Initiates Vivani Medical(VANI.US) With Buy Rating, Announces Target Price $3

Moomoo NewsNov 7 06:31 ET

Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsSep 27 10:31 ET

Buy Rating Affirmed for Vivani Medical on Strong Potential of NPM-115 Implant for Metabolic Disease Treatment

TipRanksSep 5 10:33 ET

Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsSep 5 10:32 ET

Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsAug 15 10:31 ET

Buy Rating Justified: Vivani Medical's Promising NPM-115 Implant and Strategic Market Positioning

TipRanksMay 15 12:40 ET

Maxim Group Reaffirms Their Buy Rating on Vivani Medical (VANI)

TipRanksAug 16, 2023 14:35 ET

Vivani Medical Analyst Ratings

Benzinga Analyst RatingsDec 5, 2022 09:18 ET

ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7

Benzinga Real-time NewsDec 5, 2022 09:18 ET